NCT03847285 (Immune-Mo) is a clinical trial of solid organ transplantation in Transplant, sponsored by Rigshospitalet, Denmark.

Who is sponsoring NCT03847285?

NCT03847285 is sponsored by Rigshospitalet, Denmark.

What drugs are being tested in NCT03847285?

Interventions in NCT03847285: solid organ transplantation.

What condition does NCT03847285 study?

NCT03847285 studies Transplant.

Is NCT03847285 still recruiting?

NCT03847285 is currently active, enrolled. Last updated 10 April 2024.

Last reviewed 2024-04-10 · How we verify

NCT03847285: Immune-Mo

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Immune Function as Predictor of Infectious Complications and Clinical Outcome in Patients Undergoing Solid Organ Transplantation

Active, enrolled Last updated 10 April 2024

What this trial tests

trial testing solid organ transplantation in Transplant in 188 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 April 2018

Primary endpoint
31 January 2022

31 January 2026

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	188
Start date	1 April 2018
Primary completion	31 January 2022
Estimated completion	31 January 2026
Sites	1 location across Denmark

Drugs / interventions tested

solid organ transplantation

Conditions studied

Transplant — all drugs for Transplant →

Sponsor

Rigshospitalet, Denmark

Who can join

18 and older, any sex, with Transplant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

At Rigshospitalet, Denmark, we will examine the immune function of solid organ transplant recipients before and at several timepoints after transplantation as well as the clinical outcome, especially the risk of infections complications and graft rejections. The immune function will be assessed with a complete immunological profiling consisting of immune phenotype (flow cytometry), immune function (TruCulture®) and circulating biomarkers. The study aims to generate prediction models of patients at excess risk of poor clinical outcome, with the ultimate intent to propose personalized immunosuppressive regimes to be tested in future randomized clinical trials.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial.
Drabe CH, Sørensen SS, Rasmussen A, Perch M, et al · · 2019 · cited 10× · PMID 31269923 · DOI 10.1186/s12879-019-4207-9
Prediction of herpes virus infections after solid organ transplantation: a prospective study of immune function.
Møller DL, Sørensen SS, Rezahosseini O, Rasmussen DB, et al · · 2023 · cited 5× · PMID 37465673 · DOI 10.3389/fimmu.2023.1183703
Associations Between Pre-Transplantation T Cell Populations and Acute Cellular Rejection Post-Liver Transplantation-Results From a Prospective Cohort Study.
Clemmesen JLR, Suarez-Zdunek MA, Møller DL, Hove-Skovsgaard M, et al · · 2025 · cited 1× · PMID 40830915 · DOI 10.1111/sji.70048
Impact of MyD88 Deficiency on Innate Immune Function in COVID-19 Infection and Allotransplantation.
Lee SF, Woolley A, Sharma NS. · · 2023 · cited 1× · PMID 37749810 · DOI 10.1097/tp.0000000000004725

Verify or expand the search:

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03847285 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 10 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03847285.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing